South Shore Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
South Shore Capital Advisors's LLY Position: Q2 2026 in Review
South Shore Capital Advisors increased its Eli Lilly (LLY) stake by 6.3% in Q2 2026, buying an estimated $23.5K and bringing the position to 387 shares worth $464K. The position accounts for 0.31% of the portfolio, ranked #75.
South Shore Capital Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- South Shore Capital Advisors held 387 shares of Eli Lilly worth $464K as of Q2 2026.
- South Shore Capital Advisors bought 23 Eli Lilly shares in Q2 2026, an estimated $23.5K.
- Eli Lilly made up 0.31% of South Shore Capital Advisors's portfolio in Q2 2026, its #75 holding.
- South Shore Capital Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on South Shore Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.